Literature DB >> 1165111

Organ distribution of sheep red blood cells in ALS-treated rats.

P Kinnaert, A Mahieu, N Van Geertruyden, R d'Orchimont, R Goossens.   

Abstract

The inter-organ distribution of radioactivity in rats injected with 51Cr-labelled SRBC is altered after treatment with ALS absorbed with this antigen. The alteration is due to the presence of soluble SRBC antigens in the serum and subsequent immunization of the tested animals. The 51Cr distribution does not correspond to the uptake of antigenic material in immunized rats.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1165111      PMCID： PMC1445976     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  6 in total

1.  Clinical determination of the sites of red cell sequestration in hemolytic anemias.

Authors:  J H JANDL; M S GREENBERG; R H YONEMOTO; W B CASTLE
Journal:  J Clin Invest       Date:  1956-08       Impact factor: 14.808

2.  Reticuloendothelial function in immune-suppressed animals.

Authors:  J C Pisano; J T Patterson; N R Di Luzio
Journal:  J Reticuloendothel Soc       Date:  1972-10

3.  Use of minimal doses of lymphoid cells for production of heterologous antilymphocyte serum.

Authors:  J J Gozzo; M L Wood; A P Monaco
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

4.  Effect of different types of antilymphocytic serum on phagocytosis in rats.

Authors:  P Kinnaert; A Mahieu; R Penneman
Journal:  J Reticuloendothel Soc       Date:  1972-11

5.  Mechanism of reticuloendothelial system blockade produced by antilymphocyte serum.

Authors:  J N Sheagren; R F Barth; J B Edelin; R A Malmgren
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

6.  The loss of the immunosuppressive properties of anti-lymphocytic globulin following absorption with immunizing antigen (sheep erythrocytes).

Authors:  D Allan; J Elson; W P Duffus; K James
Journal:  Clin Exp Immunol       Date:  1971-01       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.